Replication/NN
of/IN
type/NN
1/CD
human/JJ
immunodeficiency/NN
viruses/NNS
containing/VBG
linker/NN
substitution/NN
mutations/NNS
in/IN
the/DT
-201/CD
to/TO
-130/CD
region/NN
of/IN
the/DT
long/JJ
terminal/JJ
repeat/NN
./.

In/IN
previous/JJ
transfection/NN
analyses/NNS
using/VBG
the/DT
chloramphenicol/JJ
acetyltransferase/NN
reporter/NN
gene/NN
system/NN
,/,
we/PRP
determined/VBD
that/IN
linker/NN
substitution/NN
(/(
LS/NN
)/)
mutations/NNS
between/IN
-201/CD
and/CC
-130/CD
(/(
relative/JJ
to/TO
the/DT
transcription/NN
start/NN
site/NN
)/)
of/IN
the/DT
human/JJ
immunodeficiency/NN
virus/NN
type/NN
1/CD
long/JJ
terminal/JJ
repeat/NN
(/(
LTR/NN
)/)
caused/VBD
moderate/JJ
decreases/NNS
in/IN
LTR/NN
transcriptional/JJ
activity/NN
in/IN
a/DT
T-cell/NN
line/NN
(/(
S.L.Zeichner/NNP
,/,
J.Y.H./NNP
Kim/NNP
,/,
and/CC
J.C.Alwine/NNP
,/,
J.Virol.65/NNP
:/:
2436-2444/CD
,/,
1991/CD
)/)
./.
=====
In/IN
order/NN
to/TO
confirm/VB
the/DT
significance/NN
of/IN
this/DT
region/NN
in/IN
the/DT
context/NN
of/IN
viral/JJ
replication/NN
,/,
we/PRP
constructed/VBD
several/JJ
of/IN
these/DT
LS/NN
mutations/NNS
(/(
-201/CD
to/TO
- 184/CD
,/,
-183/CD
to/TO
-166/CD
,/,
-165/CD
to/TO
-148/CD
,/,
and/CC
-148/CD
to/TO
-130/CD
)/)
in/IN
proviruses/NNS
and/CC
prepared/VBD
viral/JJ
stocks/NNS
by/IN
cocultivation/NN
of/IN
transfected/VBN
RD/NN
cells/NNS
with/IN
CEMx174/NN
cells/NNS
./.
=====
In/IN
addition/NN
,/,
two/CD
mutations/NNS
between/IN
-93/CD
and/CC
-76/CD
and/CC
between/IN
-75/CD
and/CC
-58/CD
were/VBD
utilized/VBN
,/,
since/IN
they/PRP
affect/VBP
the/DT
nuclear/JJ
factor/NN
kappa/NN
B/NN
(/(
NF-kappa/NN
B/NN
)/)
-/:
and/CC
Sp1-binding/JJ
sites/NNS
and/CC
were/VBD
expected/VBN
to/TO
diminish/VB
viral/JJ
replication/NN
./.
=====
Our/PRP$
results/NNS
suggest/VBP
that/IN
while/IN
transfection/NN
analyses/NNS
offer/VBP
an/DT
adequate/JJ
approximation/NN
of/IN
the/DT
effects/NNS
of/IN
the/DT
LS/NN
mutations/NNS
,/,
the/DT
analysis/NN
of/IN
viral/JJ
replication/NN
using/VBG
a/DT
mutant/JJ
viral/JJ
stock/NN
presents/VBZ
a/DT
more/RBR
accurate/JJ
picture/NN
,/,
which/WDT
is/VBZ
sometimes/RB
at/IN
variance/NN
with/IN
the/DT
transfection/NN
results/NNS
./.
=====
Three/CD
mutants/NNS
(/(
-201/-184/CD
NXS/NN|NNS
,/,
-165/-148/CD
NXS/NN|NNS
,/,
and/CC
-147/-130/CD
NXS/NN|NNS
)/)
had/VBD
effects/NNS
on/IN
viral/JJ
replication/NN
that/WDT
were/VBD
much/RB
more/RBR
severe/JJ
than/IN
the/DT
effects/NNS
predicted/VBN
from/IN
their/PRP$
performance/NN
in/IN
transfection/NN
analyses/NNS
,/,
and/CC
the/DT
effects/NNS
of/IN
two/CD
LS/NN
mutations/NNS
(/(
-201/-184/CD
NXS/NN
and/CC
-183/-166/CD
NXS/NN
)/)
were/VBD
not/RB
predicted/VBN
by/IN
their/PRP$
effects/NNS
in/IN
transfection/NN
./.
=====
In/IN
addition/NN
,/,
we/PRP
observed/VBD
cell/NN
type-specific/JJ
permissiveness/NN
to/TO
replication/NN
of/IN
some/DT
mutant/JJ
viruses/NNS
./.
=====
In/IN
the/DT
cell/NN
types/NNS
tested/VBN
,/,
the/DT
LS/NN
mutations/NNS
indicated/VBD
an/DT
apparent/JJ
requirement/NN
not/RB
only/RB
for/IN
the/DT
intact/JJ
NF-kappa/NN
B/NN
and/CC
SP1-binding/JJ
sites/NNS
but/CC
also/RB
for/IN
several/JJ
regions/NNS
between/IN
-201/CD
and/CC
-130/CD
not/RB
previously/RB
associated/VBN
with/IN
viral/JJ
infectivity/NN
./.